Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
9.57
-0.13 (-1.34%)
At close: Jan 30, 2025, 4:00 PM
9.51
-0.06 (-0.63%)
After-hours: Jan 30, 2025, 4:10 PM EST
Anavex Life Sciences Cash Flow Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
| Net Income | -43 | -43 | -47.51 | -47.98 | -37.91 | -26.28 | |
| Stock-Based Compensation | 9.44 | 9.44 | 16.37 | 18.38 | 8.23 | 4.88 | |
| Other Operating Activities | - | - | 0.85 | - | - | - | |
| Change in Accounts Payable | 5.31 | 5.31 | 0.5 | -0.91 | 0.75 | 0.47 | |
| Change in Unearned Revenue | -0.08 | -0.08 | 0.47 | - | 0.44 | - | |
| Change in Other Net Operating Assets | -2.48 | -2.48 | 1.54 | 6.28 | -1.9 | -0.35 | |
| Operating Cash Flow | -30.81 | -30.81 | -27.79 | -24.24 | -30.38 | -21.29 | |
| Issuance of Common Stock | 11.98 | 11.98 | 29.65 | 22 | 158.79 | 28.75 | |
| Other Financing Activities | - | - | - | -0.71 | -5.55 | -0.4 | |
| Financing Cash Flow | 11.98 | 11.98 | 29.65 | 21.29 | 153.24 | 28.35 | |
| Net Cash Flow | -18.84 | -18.84 | 1.87 | -2.95 | 122.86 | 7.06 | |
| Free Cash Flow | -30.81 | -30.81 | -27.79 | -24.24 | -30.38 | -21.29 | |
| Free Cash Flow Per Share | -0.37 | -0.37 | -0.35 | -0.32 | -0.44 | -0.37 | |
| Cash Income Tax Paid | 0.3 | 0.3 | 0.14 | 0.33 | 0.14 | 0.02 | |
| Levered Free Cash Flow | -19.43 | -19.43 | -14.27 | -6.03 | -15.9 | -11.7 | |
| Unlevered Free Cash Flow | -19.43 | -19.43 | -14.27 | -6.03 | -15.9 | -11.7 | |
| Change in Net Working Capital | -2.75 | -2.75 | -2.51 | -5.38 | 0.72 | -0.12 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.